Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer

Hao Wang(Nanfang Hospital), Guoxin Li(Nanfang Hospital), Qingbin Yang(Key Laboratory of Guangdong Province), Hao Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yihao Zhang(Key Laboratory of Guangdong Province), Jiayong He(Key Laboratory of Guangdong Province), Yanmei Peng(Peking University Shenzhen Hospital), Fengping Li(Key Laboratory of Guangdong Province), Jing Wu(Union Hospital), Guofan Zhang(Chinese Academy of Sciences), Boyang Zheng(Key Laboratory of Guangdong Province), Ruoyu Ling(Key Laboratory of Guangdong Province), Chaorui Wu(Nanfang Hospital), Xuetao Lei(Key Laboratory of Guangdong Province), Gengtai Ye(Key Laboratory of Guangdong Province)
Molecular Therapy — Oncolytics
February 1, 2022
10.1016/j.omto.2022.01.008
Cited by 13

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Circular RNA circRHOBTB3 acts as a sponge for miR-654-3p inhibiting gastric cancer growth
|Journal of Experimental & Clinical Cancer Research|2020|269
Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram
|Nature Communications|2021|207
Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis
|Theranostics|2020|204
H<sub>2</sub>O<sub>2</sub> Self‐Producing Single‐Atom Nanozyme Hydrogels as Light‐Controlled Oxidative Stress Amplifier for Enhanced Synergistic Therapy by Transforming “Cold” Tumors
|Advanced Functional Materials|2022|200